Anthera Pharmaceuticals Forecast and Stock Analysis
Technical ANTH stock analysis for Friday June 14, 2019.
Anthera Pharmaceuticals gained 5.41% in the last trading day ( Friday, 14th Jun 2019 ), rising from $0.06 to $0.06 During day the stock fluctuated 24.08% from a day low at $0.05 to a day high of $0.06. The price has been going up and down for this period, and there has been a 7.32% gain for the last 2 weeks. Volume fell in the last day by -7 867 shares, and in total, 10 811 shares bought and sold for approximately $678.07. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ANTH stock price was $0.09 and low was $0.05.
- 90 day high was $0.10 and low was $0.05.
- 52 week high for the Anthera Pharmaceuticals - $0.33 and low - $0.01.
Anthera Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.38% during the next 3 months and, with 90% probability hold a price between $0.03 and $0.05 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday June 13, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Anthera Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.07. On a fall, the stock will find some support from the short-term average at $0.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 42 and the stock is currently not being overbought or oversold
Support & Resistance
Anthera Pharmaceuticals finds support from accumulated volume at $0.06.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.01 between high and low, or 24.08%. For the last week the stock has had a daily average volatility of 22.69%.
Our recommended stoploss: $0.06 (-5.01%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
22.69 %Average volatility
Very Low Low Medium High Very High
Anthera Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ANTH $0.06 ($0.00 5.41%)|
ANTH is up $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ANTH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ANTH analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us